Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last --
Change Today 0.00 / 0.00%
Volume 0.0
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Helmut Kraft

Chief Financial Officer and Member of Executive Board, Stada-Arzneimittel AG
AgeTotal Calculated CompensationThis person is connected to 9 board members in 1 different organizations across 4 different industries.

See Board Relationships
As of Fiscal Year 2014


Mr. Helmut Kraft has been the Chief Financial Officer and Member of Executive Board at Stada-Arzneimittel AG since January 1, 2010. A trained attorney, Mr. Kraft served as Head of Group Finance, Taxes and Investments at the PHOENIX group, a leading European pharmaceutical wholesaler, since 1996. He served at Landis & Gyr Holding GmbH (Siemens Building Technologies) as Head of Finance and Taxes from 1996 to 2009 and at KPMG Deutsche Treuhand-Gesellschaft, Aktiengesellschaft, ...

Read Full Background

Corporate Headquarters*

Stadastrasse 2-18
Bad Vilbel, -- 61118


Phone: 49 6101 6030
Fax: 49 6101 603 259

Board Members Memberships*

There is no Board Members Memberships data available.


Unknown/Other Education 1987
University of Heidelberg

Other Affiliations*

Annual Compensation*

Total Annual Compensation€1,149,000

Stock Options*

Long Term Incentive Plan€1,575,000
All Other Compensation€26,000

Total Compensation*

Total Annual Cash Compensation€1,175,000
Total Short Term Compensation€1,149,000
Other Long Term Compensation€26,000
Total Calculated Compensation€2,750,000
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
STDAY:US $0.00 USD 0.00


Clive A. Meanwell M.D., Ph.D.Chairman and Chief Executive Officer
The Medicines Company
George Frederick Wilkinson Chief Executive Officer, President and Director
Impax Laboratories Inc.
Karl-Ludwig Kley Chairman of Executive Board and Chief Executive Officer
Merck KGaA
Jean-Christophe Tellier Chief Executive Officer and Executive Director
Gunupati Venkateswara Prasad B.Sc. (Chem. Eng.), M.S. (Indl. Admn.)Co-Chairman, Chief Executive Officer, Member of The Management Council, Director, Member of Management Committee, Member of Stakeholders' Relationship Committee, Member of Investment Committee and Member of Corporate Social Responsibility Committee
Dr. Reddy's Laboratories Ltd.
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact STADA ARZNEIMITTEL-UNSPN ADR, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at